NK Cell and Ig Interplay in Defense Against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation
Overview
Authors
Affiliations
HSV-1 latently infects most humans, causing a variable clinical picture that depends, in part, on host genetic factors. Both IgG and its cellular FcRs, CD16A and CD32A-C (encoded by FCGR3A and FCGR2A-C, respectively, on chromosome 1), display polymorphisms that could affect their defensive function. Of potential relevance are a FCGR3A dimorphism resulting in CD16A-valine/phenylalanine-158 allotypes with different IgG affinity, variations conditioning NK cell expression of CD32B or CD32C, and IgG1 H chain (IGHG1) and kappa-chain (IGKC) polymorphisms determining allotypes designated G1m and Km. In this study, we assessed the contribution of Ig genetic variations and their interaction with FcR polymorphism to HSV-1 susceptibility, as well as their impact on NK cell-mediated Ab-dependent cellular cytotoxicity (ADCC). Our results show an epistatic interaction between IGHG1 and FCGR3A such that the higher affinity CD16A-158V/V genotype associates with an asymptomatic course of HSV-1 infection only in homozygotes for G1m3. Furthermore, CD16A-158V and G1m3 allotypes enhanced ADCC against opsonized HSV-1-infected fibroblasts. Conversely, Km allotypes and CD32B or CD32C expression on NK cells did not significantly influence HSV-1 susceptibility or ADCC. NK cells degranulating against immune serum-opsonized HSV-1-infected fibroblasts had heterogeneous phenotypes. Yet, enhanced ADCC was observed among NK cells showing a differentiated, memory-like phenotype (NKG2C(bright)NKG2A(-)CD57(+)FcRγ(-)), which expand in response to human CMV. These results extend our knowledge on the importance of immunogenetic polymorphisms and NK cell-Ab interplay in the host response against HSV-1 and point to the relevance of interactions between immune responses elicited during chronic coinfection by multiple herpesviruses.
Graninger M, Endmayr V, Kuhner L, Berger S, Rommer P, Klotz S J Med Virol. 2024; 96(12):e70091.
PMID: 39610330 PMC: 11605371. DOI: 10.1002/jmv.70091.
Slein M, Backes I, Kelkar N, Garland C, Khanwalkar U, Sholukh A bioRxiv. 2024; .
PMID: 39605495 PMC: 11601663. DOI: 10.1101/2024.11.20.624598.
NKG2C Sequence Polymorphism Modulates the Expansion of Adaptive NK Cells in Response to Human CMV.
Asenjo J, Moraru M, Al-Akioui-Sanz K, Altadill M, Muntasell A, Lopez-Botet M HLA. 2024; 104(5):e15764.
PMID: 39581700 PMC: 11586157. DOI: 10.1111/tan.15764.
Pandey J, Baglio F, Mancuso R, Guerini F, Cabinio M, Isernia S J Neurol Sci. 2024; 464:123167.
PMID: 39142084 PMC: 11347077. DOI: 10.1016/j.jns.2024.123167.
Tittarelli A, Pereda C, Gleisner M, Lopez M, Flores I, Tempio F Vaccines (Basel). 2024; 12(4).
PMID: 38675738 PMC: 11053591. DOI: 10.3390/vaccines12040357.